Cancer research

Accelerating Research to Improve Health

The UCSF Clinical and Translational Science Institute (CTSI) is part of the Clinical and Translational Science Award (CTSA) program funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) (Grant Number UL1 TR001872). The content of this website is solely the responsibility of CTSI and does not necessarily represent the official views of the NIH.

Cite CTSI NIH Funding Acknowledgment: Important — All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH Funding acknowledgment and must comply with NIH Public Access Policy.

Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.

10th Biennial Helene Harris Memorial Trust meeting.

10th Biennial Helene Harris Memorial Trust meeting.

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

Head and neck cancer: meeting summary and research opportunities.

Head and neck cancer: meeting summary and research opportunities.

Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.

SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.

SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.

Pages

Search form

You are here

Cancer research

Pages